MedLab 2024
)
Oxford Nanopore are exhibiting and presenting at this event. MedLab is powering medical laboratory growth in the Middle East and beyond with global reach and local focus. The event is the hub for industry professionals where challenges are addressed, tailored solutions and strategies are offered to encourage more opportunities in medical laboratories contributing to the overall healthcare growth.
Oxford Nanopore will be hosting an Industry Workshop 'Revealing more biology using nanopore sequencing to transform population genomics' on Wednesday 7th February from 15:30 - 16:30, in the NextGen Zone. Please register below to secure your place.
Ask bolder questions. Make no compromises. What you’re missing matters.
The complete characterisation, analysis and cataloguing of human genetic variation at the population scale is becoming increasingly important to better enable the identification of disease-causing variants in the clinic. Relying on traditional analysis, platforms may miss important sources of genomic variation, limiting the utility of the data. Nanopore technology offers rapid and affordable access to the high outputs of high-quality data required for large-scale population genomics projects as well as enabling the generation of highly contiguous genomes, with resolution and phasing of single nucleotide variants (SNVs), structural variants (SVs), repeats, and DNA methylation in a single assay.
Stay on top of what’s next.
Learning objectives
Understand the impact of employing a comprehensive and scalable sequencing technology for human population genomics at a regional and global level.
Discover the complete view of human genomic variation possible in a single dataset from nanopore and how this can power the bigger and bolder research questions that will transform human health.
Learn how to get all the rich data you need from sequencing native DNA molecules in a single platform with a range of analysis tools available for nanopore sequencing, including real time basecalling, alignment & mods, workflows in EPI2ME and tertiary analysis options.
Visit us at Booth #Z5.F28 if you are able to attend the event.
Agenda
15:30 – 16:30 hrs GST | Agenda (subject to change) | |
|---|---|---|
15:30 – 15:55 hrs | Population Scale Genomics with nanopore sequencing | Rich Carter, Oxford Nanopore Technologies |
15:55 – 16:20 hrs | Title to follow | Dr Fatiha Benslimane, Biomedical Research Center / Qatar University |
16:20– 16:30 hrs | Q&A discussion | Graham Hall, Oxford Nanopore Technologies |
Speakers
)
Richard Carter, Senior Director, Strategic Integrations, Oxford Nanopore TechnologiesRichard Carter has worked in various roles at Oxford Nanopore Technologies since 2010. He is currently the Senior Director for the Strategic Integrations Team ensuring that Oxford Nanopore products can be integrated into the customer’s wider ecosystems from LIMS integration for sample preparation through to secondary and tertiary analysis and beyond to electronic health records. As such, he works closely with many customers throughout the world, translating their needs into projects for the in-house product development teams. He leads a team writing the software to support those integrations as well as personnel responsible for designing solutions for variant interpretation and annotation for rare diseases and oncology use cases.
His experiences in the wet lab as a protein and nucleic acid crystallographer are a fundamental reason he turned to Computational Biology and Bioinformatics. He has now worked In Bioinformatics for over 20 years and in Next Generation Sequencing for a generation. He has seen the field grow from working for Solexa when read lengths were just 18 bases to now working with megabase length reads for Oxford Nanopore. He has worked on human genomic or large-scale projects for much of that time and so has continually faced and overcome many data storage and management challenges. He has led high throughput computing teams, data management and analysis teams as well as database administration and cloud infrastructure teams and with many frontend, backend and full-stack software development teams.
)
Fatiha Benslimane, Research Associate, Biomedical Research Center / Qatar UniversityFatiha Benslimane is a research associate at Qatar University with expertise in Oxford Nanopore sequencing across environmental, health, and clinical applications. Her research focuses on metagenomics, COVID-19 genomics, marine biology, and translational medicine.
